RAFAEL HOLDINGS, INC. Stock Issued During Period, Shares, New Issues
RAFAEL HOLDINGS, INC. (RFL) reported Stock Issued During Period, Shares, New Issues of 13.77 thousand shares for the 1-month period ending 2024-01-31, per its 10-Q filed 2024-06-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-12-20
- 2024-01-31: Stock Issued During Period, Shares, New Issues 1 month 13.77K shares.
- 2024-01-05: Stock Issued During Period, Shares, New Issues 101.40K shares.
- 2023-10-25: Stock Issued During Period, Shares, New Issues 135.00K shares.
- 2023-08-28: Stock Issued During Period, Shares, New Issues 111.41K shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 6 month |
|---|---|---|---|---|
| 2024-01-31 | 13.77K shares 10-Q · filed 2024-06-14 | |||
| 2024-01-05 | 101.40K shares 10-Q · filed 2024-06-14 | |||
| 2023-10-25 | 135.00K shares 10-K/A · filed 2024-12-20 | |||
| 2023-08-28 | 111.41K shares 10-Q · filed 2024-06-14 | |||
| 2023-08-01 | 4.00M shares 10-K/A · filed 2024-12-20 | |||
| 2023-05-02 | 2.51M shares 10-K/A · filed 2024-12-20 | |||
| 2023-04-07 | 4.30K shares 10-Q · filed 2024-06-14 | |||
| 2023-01-31 | 120.02K shares 10-Q · filed 2023-06-13 | 120.02K shares 10-Q · filed 2023-03-14 | ||
| 2022-06-14 | 452.13K shares 10-Q · filed 2023-03-14 | 452.13K shares 10-Q · filed 2023-06-13 | ||
| 2022-02-01 | 986.84K shares 10-Q · filed 2023-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |